Academic Journal
Quartile not availableHuman Psychopharmacology Clinical and Experimental
About Human Psychopharmacology Clinical and Experimental
About Human Psychopharmacology Clinical and Experimental
Human Psychopharmacology Clinical and Experimental is a peer-reviewed scholarly journal published by Wiley.
Key indicators: ISSN 08856222, 10991077.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
Publishing in Human Psychopharmacology Clinical and Experimental
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Human Psychopharmacology Clinical and Experimental?
08856222, 10991077.
Who publishes Human Psychopharmacology Clinical and Experimental?
Wiley.
Where do I submit to Human Psychopharmacology Clinical and Experimental?
Via the official website.
Is Human Psychopharmacology Clinical and Experimental peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Serum Tau and α‐Synuclein in Children With Attention‐Deficit/Hyperactivity Disorder: Cross‐Sectional Associations With Methylphenidate Treatment
Deniz Doğan, Elvan İşeri, Aybeniz Civan Kahve, Samet Can Demirci et al.
2026-11 · DOI: 10.1002/hup.70068Acute Caffeine Intake Does Not Modulate Active or Reactive Inhibition in Non‐Clinical Young Adults, and ADHD Symptoms Do Not Moderate Its Effects
Ahmet Altınok
2026-11 · DOI: 10.1002/hup.70067Serum Complement Component 4A and Neurofilament Light Chain Levels Before and After Risperidone Monotherapy in Patients With Psychosis
Rakesh R. Biradar, Rachna Gupta, Shruti Srivastava, Seema Jain et al.
2026-11 · DOI: 10.1002/hup.70065Issue Information
2026-11 · DOI: 10.1002/hup.70030Tirzepatide Initiation in Lithium‐Treated Bipolar Disorder: Renal Biomarker Trajectories and Lithium Safety Signals Over 12 Months in a Real‐World Cohort
Maria Beatrice Rescalli, Andrea Fagiolini, Pietro Carmellini, Mario Pinzi et al.
2026-11 · DOI: 10.1002/hup.70066Association of Concomitant Amlodipine Use With Serum Olanzapine Concentrations and Clinical Outcomes in Patients With Schizophrenia
Xiaoxiao Chen, Jing Ma, Xiaolei Xuan, Mao Huang et al.
2026-09 · DOI: 10.1002/hup.70062Correlation Analysis of Blood Lithium Metabolism Kinetics and Concentration‐to‐Dose Ratio in Patients With Hypertension and Manic Episodes
Dan Liao, Mingchao Li, Zijun Xiong, Qiuming Ji et al.
2026-09 · DOI: 10.1002/hup.70064Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives
José Norberto Vásquez‐Bonilla
2026-09 · DOI: 10.1002/hup.70063A Systematic Review and a VigiBase Study of Accidental Clozapine Intoxications in Children and Adolescents
Sara Jiménez‐Fernández, Carlos De las Cuevas, Emilio J. Sanz, Jose de Leon et al.
2026-09 · DOI: 10.1002/hup.70059Psychopharmacological Mechanisms of Antidepressant Withdrawal: Insights From Venlafaxine
Elliot McClure
2026-09 · DOI: 10.1002/hup.70061Empathic Accuracy and Behavioral Empathy After a Moderate Dose of Beer
Isabelle Cristina Baltariu, Violeta Enea, Teresa B. Prucker, Marije aan het Rot et al.
2026-09 · DOI: 10.1002/hup.70060The Impact of Citicoline/Phosphatidylserine Supplementation on Cognitive Performance and Executive Functions in Mental Disorders: A Systematic Review of Controlled Trials
Nazan Gundogan Kucuksahin, Tugce Turan Kaya, Eren Halac, Ekin Sut et al.
2026-09 · DOI: 10.1002/hup.70058Issue Information
2026-09 · DOI: 10.1002/hup.70029Assessment of the Efficacy of Quercetin in Adult Patients With Autism Spectrum Disorder: A Randomized, Triple‐Blind, Placebo‐Controlled Trial
Anahid Rezaeifar, Mahtab Motamed, Niayesh Mohebbi
2026-07 · DOI: 10.1002/hup.70057Relationship Between Clozapine Levels and Adverse Effects Evaluated by the GASS‐C in Treatment‐Resistant Schizophrenia
Yui Okubo, Hitoki Hirose, Shohei Nishimon, Hitoshi Maeshima et al.
2026-07 · DOI: 10.1002/hup.70055Evaluation of Oculomotor Function Following Sleep Improvement With Lemborexant in Older Adults With Insomnia
Seiko Miyata, Keita Kawai, Kunihiro Iwamoto, Ippei Okada et al.
2026-07 · DOI: 10.1002/hup.70056ADHD, Psychotropic Medication and Pregnancy: The Influence of Maternal ADHD on Child Development—A Retrospective Cohort Study
Bregje Eleonore Elisabeth Maria Bonenkamp, Elvera Andrea Damer, Peter Gerrit Johannes ter Horst
2026-07 · DOI: 10.1002/hup.70054Reviews
Community Reviews
Version History
October 10, 2026 at 7:25 pm
October 9, 2026